1/64
Looks like no tags are added yet.
T/F Drug development starts with the begininng in mind
False, end in mind
In drug development who do we need to consider the most?
The patient
T/F In chronic disease management we want to increase pill burden
False, decrease
T/F In chronic disease management we want better toleratable drugs
True
Drug substance example
API
Drug formulation example
API + excipients
Drug product example
final dosage form in packaging
If 2 different medications have the same API, but different formulation/release profile, are they bioequivalent?
No
High density system - avoiding gastric emptying
drug is so dense, it stays lodged at bottom of stomach
Swelling/expansion form - avoiding gastric emptying
hydrated polymers expand in stomach and cant get through the pyloric sphincter
What delayed gastric emptying technique does Glumteza use?
Swelling/expansion form
Bioadhesive approach - avoiding gastric emptying
adhesive polymer adhere to the stomach lining
Superporous hydrogrels - avoiding gastric emptying
quick swelling hydrogels
Floating drug delivery system - avoiding gastric emptying
low density dryg with sufficient buoyancy to float
Gastroretention
retain drug in stomach and let it slowly move into upper GI tract
What order kinetics can be achieved with osmotic pumps
zero
Basic design of an osmotic pump- 3 parts:
core with osmotic agent, semi-permiable membrane, delivery orifice
In an osmotic pump, what does the core with osmotic agent look like?
either unitary or multilayer
In an osmotic pump, what are characteristics of the semi-permiable membrane
rigid, sufficient strength, non swelling, biocompatible
2 Common excipients for semi-permiable membrane for osmotic pump
ethyl cellulose, cellulose acetate
What is the purpose of the delivery orifice in the osmotic pump?
to release the drug
What happens the the ER osmotic pump drug, if the semi permiable membrane is comprimised?
release profile will change to IR
For fixed dose combination therapies for diabetes what do we need to think about?
drugs need to be compatible, MOAs need to be complementary, pill size in mind
In combination therapies, is it okay to have 2 drugs with same MOA?
no, we want complementary MOAs
T/F semaglutide/Ozempic formulation is designed to control release kinetics
False, its designed to keep the peptide stable in and in solution
Disodium phosphate dihydrate buffer in semaglutide is for...
maintain pH (keep molecule ionized in solution)
Phenol in semaglutide is for...
antioxidant
Propylene glycol in semaglutide is for...
co-solvent in water
Given the pI of semaglutide is 5.4, why use a formulation of 7.4?
So the molecule is ionized in physiological pH, so it can stay in solution/stable
At pH 7.4, what is the net charge of ozempic?
-4
What modification was added to semaglutide to have resistance to DPP4?
Add alpha-aminoisobutyric acid (Aib) to Position 8
What modification was added to semaglutide to increase half life?
fatty acid side chain is attatched via a linker (albumin binding)
What is the name of the 1st ORAL GLP-1 RA
rybelsus, now Ozempic
What is the special ingredient in Rybelus (oral semaglutide) that makes it work?
SNAC
SNAC
salcaprozate sodium
SNAC mechanism in Rybelsus
surrounds semaglutide in the stomach, locally neutralizing gastric acid, inactivating local pepsin, boosting local solubility, and driving absoprtion in the intestine
SNAC is an acid with what tail?
carboxylic acid tail
Metformin has ____ solubility but ____ permeability (Log P)
high, low
Is metformin an acid or base
base
At physiological pH, is metformin cationic or anionic or neutral?
cationic
Where is metformin absorbed
short upper GI tract window
Why do conventional ER tablet designs not work for Metformin?
It would pass the absorption window too quickly, causing bad absorption
Why do we want to make ER tablets of metformin?
help the GI side effects
Why cant we just give higher dose/concentration to make up for the lack of permiability of metoformin?
GI side effects/tolerability and transporters are saturable
What is the swelling excipient in ER Metformin, Glumetza?
Polethylene oxide (PEO)
What is the rate-controlling polymer (drug release) in ER Metformin, Glumetza?
hypromellose
Fortamet
ER form of Metformin
Fortamet uses a ____ technology to have ER properties
SCOT- single composition osmotic technology
Why is metformin able to use SCOT- single composition osmotic technology while Glipizide can't?
metformin has high solubility while glipizide dosent
What is the excipient for Fortamet for the semi permiable barrier
Cellulose acetate
What is the excipient for Fortamet for the rate controlling polymer (drug release)
Hypromellose
What is the excipient for Fortamet for the plasticizer of the membrane
PEG 400 and PEG 8000
Can you interchange Fortamet and Glumetza?
no
BCS of metformin
3
BCS of glipizide
2
Glipizide has ____ solubility, but ____ permiability (Log P)
low, high
Is glipizide considered an acid or base
weak acid
Is glipizide anionic, cationic, or neutral at physiologic pH
anionic
Glucotrol Xl, ER glipizide uses a ____ technology
2 compartment, push pull osmotic delivery system
Push pull osmotic system
seperate osmotic agent, physical moveable partition, active drug
water enters membrane, push layer (osmotic agent) will swell and push dissolved drug through orifice at controlled rate
In Glucotrol Xl, what is the osmogen/osmotic agent used in the push pull system?
NaCl
Why is Empagliflozin BCS 3
because it is a PgP substrate, not because of Log P
Empagliflozin has ___ solubility and ____ permiability (Log P)
low, high
Is empagliflozin acid or base?
weak acid, but behaves non electrolyte at physiological pH
Why is there no ER form of Empaglifozin?
IR t1/2 is longer than metformin or glipizide